Verastem, Inc
Price
FilingsNewest: 10-Q, Quarterly reportMay 7 →InsidersNo open-market buys. 6 insiders sold $779,849, all 30 sales on a 10b5-1 plan.→HoldersBlackRock 10.2%Nantahala 7.9%Armistice Capital 7.8%→PeersClosest companies: APRE, CCCC, IDYA→
From the filings
Figures
- Revenue
- $87.5Mlast 12 months
- Net income
- −$202.7Mlast 12 months
- Operating cash flow
- −$150.9Mlast 12 months
- Cash and equivalents
- $136.4Mat the last balance sheet
- Shares outstanding
- 90.5M shareson issue